Status:
COMPLETED
Validation of a Digital Visual Analogue Scale for Appetite Measurement
Lead Sponsor:
General Mills
Conditions:
Healthy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scal...
Eligibility Criteria
Inclusion
- Healthy adults 18-70 years.
- Body mass index 20-29.9 kg/m² (based on self-reported weight and height).
- Understand the study procedures.
- Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
- Willing to follow study procedures on test days.
- Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day.
- Willing to provide informed consent to participate in the study.
Exclusion
- Pregnant or lactating women, or women who are planning to become pregnant during the study
- Known food allergies, sensitivity, or intolerance to any food or food ingredients
- Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
- Taking medications that affect appetite, metabolism, or blood pressure
- Presence of acute diseases or infection
- Presence or history of chronic diseases
- Diagnosed with eating disorders
- Restraint eaters
- Lost or gained 5 pounds or more in the past 3 months
- On a weight-loss diet, or undergoing intermittent fasting
- COVID-19 infection in the past 3 months.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05287516
Start Date
April 1 2022
End Date
May 30 2022
Last Update
November 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Remote study, No physical facility
Minneapolis, Minnesota, United States, 55427